Effects of short term add ‐on ezetimibe to statin treatment on expression of adipokines and inflammatory markers in diabetic and dyslipidemic patients
ConclusionShort‐term add‐on ezetimibe to simvastatin treatment suppressing effects on hypercholesterolemia and adiponectinemia are independent of the diabetes status. Resistin serum levels and leukocyte mRNA expression are influenced by add‐on ezetimibe to statin treatment.This article is protected by copyright. All rights reserved.
Source: Cardiovascular Therapeutics - Category: Cardiology Authors: Elizandra Silva Guimar ães, Alvaro Cerda, Egidio Lima Dorea, Marcia Martins Silveira Bernik, Maria Cecilia Gusukuma, Gelba Almeida Pinto, Cristina Moreno Fajardo, Mario Hiroyuki Hirata, Rosario Dominguez Crespo Hirata Tags: Original Research Article Source Type: research
More News: Cardiology | Cardiovascular | Cholesterol | Diabetes | Endocrinology | Heart | Simvastatin | Statin Therapy | Vytorin | Zetia | Zocor